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Abstract: Seven new cembranoids, sarcocrassocolides F–L (1–7), have been isolated from 
a  soft  coral  Sarcophyton  crassocaule.  Their  structures  were  determined  by  extensive 
spectroscopic  analysis.  Most  new  compounds  exhibited  significant  cytotoxic  activity 
against  a  limited  panel  of  cancer  cell lines, and the structure–activity  relationship was 
studied.  Compounds  1–7  were  found  to  display  significant  in  vitro  anti-inflammatory 
activity in LPS-stimulated RAW264.7 macrophage cells by inhibiting the expression of the 
iNOS protein. Compound 4 was also found to effectively reduce the level of COX-2 protein. 
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1. Introduction 
The cembrane-type compounds have been found to be the most important diterpenoidal constituents 
in marine coelenterates [1–8]. In the investigation of the bioactive metabolites from soft corals of 
Taiwanese waters, many  bioactive cembranoids have been isolated from octocorals (Alcyonaceae) 
belonging  to  the  genera  Sinularia  [9–15],  Lobophytum  [16,17],  Sarcophyton  [18–21]  and 
Pachyclavularia  [22,23].  Some  of  these  metabolites  have  been  shown  to  exhibit  cytotoxic  
activity  against  the  growth  of  various  cancer  cell  lines  [9,11,13,17–23],  and/or  anti-inflammatory  
activity [10–12,14–17]. Our recent study of the chemical constituents of the Dongsha Atoll soft coral 
S. crassocaule [24] has yielded cembranoids sarcocrassocolides A–E, which exhibited cytotoxic and 
anti-inflammatory  activities.  Our  continuing  chemical  investigation  of  the  dame  collection  of  this 
organism, with the aim of discovering further biologically active natural products, again led to the 
isolation of seven new cembranoids, sarcrocrassocolides F–L (1–7) (Chart 1). The structures of 1–7 
were  established  by  extensive  spectroscopic  analysis,  including  careful  examination  of  2D  NMR  
(
1H-
1H COSY, HMQC, HMBC and NOESY) correlations. The cytotoxicity of compounds 1–7 against 
human  breast  adenocarcinoma  (MCF-7),  human  colon  adenocarcinoma  (WiDr),  human  laryngeal 
carcinoma (HEp-2) and human medulloblastoma (Daoy) cell lines was studied, and the ability of 1–7 
to inhibit the up-regulation of pro-inflammatory iNOS (inducible nitric oxide synthase) and COX-2 
(cyclooxygenase-2) proteins in LPS (lipopolysaccharide)-stimulated RAW264.7 macrophage cells was 
also examined.  
Chart 1. Structures of Metabolites 1–7. 
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2. Results and Discussion 
The HRESIMS (m/z 429.1887 [M + Na]
+) of sarcrocrassocolide F (1) established the molecular 
formula C22H30O7, appropriate for eight degrees of unsaturation, and the IR spectrum revealed the 
presence of lactonic carbonyl (1757 cm
−1) group. The 
13C NMR and DEPT (Table 1) spectroscopic 
data showed signals of four methyls (including one acetate methyl), four sp
3 methylenes, one sp
2 
methylenes, four sp
3 methines (including three oxymethines), three sp
2 methines, two sp
3 and four sp
2 
quaternary carbons (including two ester carbonyls). The NMR signals (Tables 1 and 2) observed at Mar. Drugs 2011, 9  
 
 
996 
δC 169.3 (qC), 139.3 (qC), 121.1 (CH2), 81.1 (CH), and 37.7 (CH), and δH 6.30, 5.64 (each, 1H, d, 
J = 2.5 Hz), 4.62 (1H, t, J = 3.0 Hz), and 3.10 (1H, dt, J = 12.0, 2.5 Hz) showed the presence of an  
ʱ-methylene-γ-lactonic group by comparing the very similar NMR data of the cembranoids with the 
same  five-membered  lactone  ring  [18,19,24].  Signals  resonating  at  δC  59.1  (qC),  59.2  (CH)  and 
δH 2.57 (1H, dd, J = 6.5, 4.5 Hz) revealed the presence of a trisubstituted epoxide. The NMR signals at 
δC 84.4 (qC) and δH 7.42 (1H, brs) showed the presence of a hydroperoxy group at a methine carbon. 
One  trisubstituted and one 1,2-disubstituted double  bonds were also identified from NMR signals 
appearing at δC 128.7 (qC), 128.7 (CH), and δH 5.28 (1H, dd, J = 7.0, 1.0 Hz), and at δC 124.7 (CH), 
136.4 (CH), and δH 5.49 (1H, dt, J = 16.0, 7.5 Hz) and 5.59 (1H, d, J = 16.0 Hz), respectively. In the 
1H-
1H  COSY  spectrum,  it  was  possible  to  identify  three  different  structural  units,  which  were 
assembled with the assistance of an HMBC experiment. Key HMBC correlations of H3-18 to C-3, C-4 
and C-5; H3-19 to C-7, C-8 and C-9; H3-20 to C-11, C-12 and C-13 and H2-17 to C-1, C-15 and C-16 
permitted  the  establishment  of  the  carbon  skeleton  (Figure  1).  Furthermore,  the  acetoxy  group 
positioned  at  C-13  was  confirmed  from  the  HMBC  correlations  of  methyl  protons  of  an  acetate  
(δH 2.02) to the ester carbonyl carbon at δC 169.1 (qC) and the oxymethine carbon at 77.1 (C-13, CH). 
The J values for both H-6 and H-7 (16.0 Hz) further confirmed the presence of a trans 1,2-disubstituted 
double  bond  at  C-6  and  C-7.  On  the  basis  of  the  above  analysis,  the  planar  structure  of  1  was 
established unambiguously. 
Table 1. 
13C NMR data for compounds 1–7. 
  1 
a  2 
b  3 
b  4 
b  5 
a  6 
a  7 
a 
1  37.7, CH 
c  38.7, CH  38.2, CH  38.2, CH  41.7, CH  41.6, CH  41.4, CH 
2  35.2, CH2  35.2, CH2  36.0, CH2  34.5, CH2  32.9, CH2  32.9, CH2  32.3, CH2 
3  59.2, CH  58.7, CH  59.2, CH  59.1, CH  59.6, CH  59.1, CH  59.4, CH 
4  59.1, qC  59.0, qC  59.4, qC  59.5, qC  60.2, qC  60.1, qC  60.5, qC 
5  38.6, CH2  38.6, CH2  39.2, CH2  38.8, CH2  40.1, CH2  39.8, CH2  39.8, CH2 
6  124.7, CH  125.0, CH  121.2, CH  121.5, CH  125.7, CH  121.8, CH  121.0, CH 
7  136.4, CH  136.9, CH  138.9, CH  140.7, CH  136.1, CH  140.1, CH  140.9, CH 
8  84.4, qC  85.2, qC  72.9, qC  73.1, qC  84.9, qC  73.0, qC  73.0, qC 
9  38.7, CH2  37.1, CH2  42.3, CH2  42.0, CH2  37.7, CH2  44.6, CH2  41.6, CH2 
10  22.0, CH2  21.4, CH2  22.0, CH2  21.8, CH2  21.7, CH2  22.1, CH2  22.2, CH2 
11  128.7, CH  128.3, CH  128.1, CH  130.1, CH  130.6, CH  131.1, CH  130.5, CH 
12  128.7, qC  129.3, qC  127.7, qC  128.6, qC  129.1, qC  129.1, qC  129.2, qC 
13  77.1, CH  77.3, CH  76.4, CH  77.4, CH  44.1, CH2  44.6, CH2  43.3, CH2 
14  81.1, CH  81.4, CH  81.3, CH  82.0, CH  81.3, CH  82.3, CH  82.8, CH 
15  139.3, qC  139.1, qC  138.1, qC  139.0, qC  139.0, qC  139.0, qC  139.1, qC 
16  169.3, qC  169.3, qC  167.4, qC  169.4, qC  169.6, qC  169.6, qC  169.7, qC 
17  121.1, CH2  122.2, CH2  121.1, CH2  121.8, CH2  122.4, CH2  122.4, CH2  122.0, CH2 
18  18.2, CH3  18.2, CH3  19.3, CH3  18.0, CH3  17.6, CH3  17.6, CH3  17.6, CH3 
19  23.5, CH3  20.9, CH3  31.2, CH3  28.4, CH3  22.3, CH3  29.8, CH3  29.4, CH3 
20  15.2, CH3  15.2, CH3  16.4, CH3  14.6, CH3  17.0, CH3  16.9, CH3  17.2, CH3 
OAc  20.8, CH3  20.8, CH3  21.8, CH3  20.8, CH3       
  169.1, qC  169.3, qC  167.4, qC  169.3, qC       
a Spectra recorded at 125 MHz in CDCl3; 
b Spectra recorded at 100 MHz in CDCl3; 
c Deduced from DEPT. Mar. Drugs 2011, 9  
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Table 2. 
1H NMR data for compounds 1–4. 
  1 
a  2 
b  3 
b  4 
b 
1  3.10 dt (12.0, 2.5) 
c  3.13 dt (11.6, 2.4)  3.11 dt (11.6, 2.8)  3.04 ddd (11.2, 4.4, 2.4) 
2  1.84 ddd (14.5, 4.5,2.5) 
c 
1.69 ddd (14.5, 12.0, 7.0) 
1.86 m 
1.71 m 
1.82 ddd (15.2, 5.6, 2.8) 
1.72 m 
1.85 m 
1.74 m 
3  2.57 dd (6.5, 4.5)  2.58 dd (6.8, 4.8)   2.59 t (5.6)   2.64 t (6.4)  
5  2.48 dd (14.5, 7.5) 
2.27 dd (14.5, 7.5) 
2.50 dd (15.2, 6.4); 
2.30 dd (15.2, 6.4) 
2.46 t (2.8) 
2.24 t (2.4) 
2.51 dd (14.4, 6.4) 
2.21 dd (11.6, 14.4) 
6  5.49 dt (16.0, 7.5)  5.52 dt (16.0, 6.4)  5.51 m  5.51 ddd (16.0, 8.0, 6.4) 
7  5.59 d (16.0)  5.54 d (16.0)  5.49 m  5.60 d (16.0) 
9  2.22 ddd (14.5, 10.5, 5.0) 
1.37 dt (10.5, 5.0) 
1.91 m 
1.56 m 
2.04 brs 
1.45 m  
1.87 m 
1.60 m 
10  2.39 ddt (17.0, 10.5, 5.0) 
2.02 brs 
2.04 m  2.34 m 
2.05 brs 
2.15 m 
2.07 m 
11  5.28 dd (7.0, 1.0)  5.30 brs   5.30 d (8.4)   5.41 m  
13  5.38 s  5.37 s  5.38 s  5.40 brs 
14  4.62 t (3.0)  4.57 t (2.8)  4.60 t (2.8)  4.59 dd (4.4, 2.4) 
17  6.30 d (2.5) 
5.64 d (2.5) 
6.32 d (2.4) 
5.67 d (2.4) 
6.31 d (2.0) 
5.65 d (2.0) 
6.30 d (2.4) 
5.62 d (2.4) 
18  1.30 s  1.31 s  1.30 s  1.32 s 
19  1.41 s  1.35 s  1.34 s  1.30 s 
20  1.76 s  1.73 s  1.75 s  1.71 s 
8-OOH  7.42 s       
13-OAc  2.02 s  2.03 s  2.02 s  2.04 s 
a Spectra recorded at 500 MHz in CDCl3; 
b Spectra recorded at 400 MHz in CDCl3; 
c J values (Hz) in parentheses. 
Figure 1. 
1H-
1H COSY and HMBC correlations for 1, 5 and 7. 
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The  relative  structure  of  1  was  elucidated  by  the  analysis  of  NOE  correlations,  as  shown  in 
Figure 2.  It  was  found  that  H-1  (δ  3.10,  dt,  J  =  12.0,  2.5  Hz)  showed  NOE  interactions  with  
H-3 (δ 2.57, dd, J = 6.5, 4.5 Hz) and H-11 (δ 5.28, dd, J = 7.0, 1.0 Hz); therefore, assuming an  
β-orientation of H-1, H-3 should also be positioned on the β-face, and the epoxy oxygen should be 
placed on the ʱ-face. NOE correlations of H-3 with H-11 and H-7 (δ 5.59, d, J = 16.0 Hz), but not with 
H3-18 (δ 1.30, s), reflected the trans stereochemistry of epoxide. The E geometry of the trisubstituted 
double bond at C-11 and C-12 was assigned from NOE correlations of H3-20 (δ 1.76, s) with H-10ʱ 
(δ 2.39, ddt, J = 17.0, 10.5, 5.0 Hz), and H-11 with H-10β (δ 2.02, brs), in addition to the upper field 
chemical shift of C-20 (δ 15.2). H-14 (δ 4.62, t, J = 3.0 Hz) exhibited NOE correlations with both  
H-13 (δ 5.38, s) and H3-20, but not with H-1 and H-11, indicating the ʱ-orientation of both H-13 and 
H-14. One of the methylene protons at C-9 (δ 1.37, dt, J = 10.0, 5.0 Hz) exhibited NOE correlations 
with all of H-3, H-10β, H-11, H3-19 (1.41, s) and H-7, thus this C-9 proton and H3-19 should be 
positioned on the β-face. On the basis of the above findings and detailed examination of other NOE 
correlations (Figure 2), the relative structure of compound 1 was determined. 
Figure 2. Key NOESY correlations for 1 and 2. 
 
Sarcrocrassocolide G (2) possessed the same molecular formula (C22H30O7) as that of 1, as revealed 
from HRESIMS. Furthermore, it was found that the NMR spectroscopic data of 2 (Tables 1 and 2) 
were found to be close to those of 1. The overlapping proton signals at δH 5.52 and 5.54, measured in 
CDCl3, was clearly resolved by measuring the 
1H NMR spectrum in pyridine-d5 (see Experimental 
Section 3.3.2) into two mutually coupled proton (δH 5.63, dd, J = 16.0, 7.0 Hz and 5.89, d, J = 16.0 Hz), 
attributable to a trans 1,2-disubstituted double bond. The relative stereochemistry of 2 was determined 
by analysis of the NOESY spectrum of 1, also measured in pyridine-d5 (Figure 2). From the NOESY 
spectrum, it was found that H3-19 (δ 1.55, s) showed NOE interaction with H-6 (δ 5.63, dt, J = 16.0, 
7.0 Hz) and H-9a (δ 2.06, ddd, J = 10.0, 5.0, 3.5 Hz), but not with H-7, showing the β-orientation of 
H3-19.  Further  analysis  of  other  NOE  interactions  revealed  that  2  possessed  the  same  relative 
configurations at C-1, C-3, C-4, C-13 and C-14, as those of 1 (Figure 2). Therefore, 2 was found to be 
the C-8 epimer of 1. Mar. Drugs 2011, 9  
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Sarcrocrassocolide H (3) was shown by HRESIMS to possess the molecular formula C22H30O6  
(m/z 413.1937 [M + Na]
+). Comparison of the 
1H and 
13C NMR data (Tables 1 and 2) of compounds 1 
and  3  showed  that  both  compounds  should  have  similar  structures.  C-8  of  3  showed  signal  at 
upperfield δC 72.9 relative to the corresponding signal of 1 (δC 84.4), implying the presence of a 
hydroxyl group at C-8 of 3. Moreover, the reduction of 1 by triphenylphosphine afforded 3. Thus, the 
structure of 3 was established. Sarcrocrassocolide I (4) was shown to possess the same planar structure 
as that of 3 by 
1H-
1H COSY and HMBC correlations. In order to confirm the relative stereochemistry 
of 4, a reduction of 2 was performed to afford 4. Thus, 4 was found to be the C-8 epimer of 3.  
Sarcrocrassocolide  J  (5)  was  shown  by  HRESIMS  to  possess  the  molecular  formula  C20H28O5  
(m/z 371.1837 [M + Na]
+). The IR spectrum of 5 showed the absorption of lactonic carbonyl (1760 cm
−1) 
group. Comparison of the NMR data (Tables 1–3) of compounds 1 and 5 showed that the structure of 5 
should be close to that of 1, with the exception of signals assigned to C-13, where an acetoxymethine 
(δH 5.38, 1H, s; δC 77.1) in 1 was replaced by a methylene (δH 2.58, 1H, dd, J = 14.0, 5.0 Hz, δH 2.25, 
1H, dd, J = 14.0, 8.0 Hz; δC 44.1) in 5. The planar structure of 5 could be established by analyzing the 
1H-
1H COSY and HMBC correlations (Figure 1). The relative stereochemistry of 5 was confirmed by 
analyzing the key NOE correlations (Figure 3), and by comparison of these correlations with those of 1. 
The structure of sarcocrassocolide J, as shown in formula 5, was thus established. 
Sarcrocrassocolide K (6) was shown by HRESIMS to possess the molecular formula C20H28O4  
(m/z 355.1888 [M + Na]
+). Comparison of the NMR data (Tables 1 and 3) of compounds 5 and 6 
showed that both compounds have similar structures. Moreover, H3-19 (δH 1.32, s) and C-8 (δC 73.0) 
of 6 displayed signals at upper field in comparison with the corresponding signals of 5 (δH 1.40, H3-19; 
δC 84.9, C-8), showing the presence of a hydroxy group at C-8 of 6. Furthermore, reduction of 5 with 
triphenylphosphine was found to give 6. Thus, the structure of 6 was established. 
Sarcrocrassocolide  L (7)  was shown by HRESIMS  to possess the molecular formula  C20H28O4  
(m/z 355.1885 [M + Na]
+). Comparison of the NMR data (Tables 1 and 3) of compounds 6 and 7 
showed both compounds could be C-8 epimers. The planar structure of 7 was also confirmed by the 
1H-
1H COSY and HMBC correlations (Figure 1). The relative configuration of 7, which should be the 
C-8 epimer of 6, was determined by key NOE correlations (Figure 3). 
Figure 3. Key NOESY correlations for 5 and 7. 
 Mar. Drugs 2011, 9  
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Table 3. 
1H NMR data for compounds 5–7. 
  5 
a  6 
a  7 
a 
1  2.80 ddd (10.5, 5.0, 3.0) 
c  2.79 ddd (10.5, 5.5, 3.0)  2.84 ddd (10.5, 5.5, 2.5) 
2  1.83 ddd (15.5, 10.5, 5.5) 
1.78 ddd (15.5, 7.0, 3.0) 
1.90 m  
1.75 ddd (14.5 , 7.5, 3.0) 
1.83 m 
3  2.66 dd (7.0, 5.5)  2.71 dd (7.5, 4.5)  2.71 t (6.0) 
5  2.60 dd(14.0, 5.0) 
2.15 dd (14.0, 6.5 ) 
2.58 m 
2.15 ddd (26.0 , 10.5, 3.0 ) 
2.58 dd (15.0, 6.0) 
2.12 dd (15.0, 8.0) 
6  5.57 ddd (16.0, 6.5, 5.0)  5.53 m  5.53 ddd (16.0, 8.0, 6.0) 
7  5.58 d (16.0)  5.55 d (16.0)  5.61 d (16.0) 
9  2.04 m 
1.51 m 
1.91 m 
1.57 m 
1.73 m 
10  2.34 dt (13.5, 8.0) 
2.02 m 
2.28 d (8.0) 
2.06 m 
2.19 m 
2.09 m 
11  5.23 brs  5.24 t (6.5)  5.29 t (7.0)  
13  2.58 dd (14.0, 5.0) 
2.25 dd (14.0, 8.0) 
2.59 dd (15.0, 5.5) 
2.26 d (8.0) 
2.55 dd (15.0, 6.0) 
2.35 dd (15.0, 6.0) 
14  4.49 dt (8.0, 5.0)  4.47 dt (8.0, 5.5)  4.47 q (6.0) 
17  6.32 d (2.5) 
5.62 d (2.5) 
6.33 d (2.5) 
5.63 d (2.5) 
6.31 d (3.0) 
5.60 brs 
18  1.32 s  1.33 s  1.34 s 
19  1.40 s  1.32 s  1.30 s 
20  1.67 s  1.67 s  1.65 s 
13-OAc       
a Spectra recorded at 500 MHz in CDCl3; 
b Spectra recorded at 400 MHz in CDCl3; 
c J values (Hz) in parentheses. 
It is noteworthy to mention that metabolites 1–7 are cembranoids possessing an ʱ-methylene-γ-lactonic 
group with a rarely found trans 6,7-disubstituted double bond, which has been discovered previously 
only in the soft coral Eunicea pinta [4]. These compounds could be the oxidized products of the related 
7,8-olefinic analogues, although we have not yet successfully discovered that a cembranoid with the 
7,8-double bond was converted into the corresponding 8-hydroxy or 8-hydroperoxy derivative under 
air in our laboratory. The cytotoxicity of compounds 1–7 against the proliferation of a limited panel of 
cancer cell lines, including Daoy, HEp-2, MCF-7 and WiDr carcinoma cell lines was evaluated. The 
results (Table 4) showed that compounds 1–4 were found to exhibit cytotoxicity against all or part of 
the above carcinoma cell lines, while compound 4 (ED50 values of 5.1 ±  1.2, 5.8 ±  0.5, 8.4 ±  1.5 and  
6.4 ±  2.0 μM against above carcinoma cell lines, respectively) is the most potent one. Compound 5, the 
13-deacetoxy derivative of 1, with ED50 values of >20 μM against above carcinoma cell lines and 
compound 7, the 13-deacetoxy derivative of 4, with ED50 values of >20 μM against above carcinoma 
cell lines, are less cytotoxic than 1 and 4, respectively; therefore, it was suggested that the acetoxy 
group  of  C-13  is  important  for  the  cytotoxicity  of  compounds  1–7.  Compound  1  (ED50  value  of  
19.4 ±  2.4 μM against MCF-7 cells) which is the 8-peroxidized form of 3 (ED50 values of 9.4 ±  2.5 μM 
against MCF-7 cells), 2 (ED50 values of 8.3 ±  1.4, 16.5 ±  1.7 and 18.9 ±  1.9 μM against Daoy, HEp-2 
and WiDr cells, respectively) which is the 8-peroxidized form of 4, and 5 (ED50 values of >20 μM 
against Daoy, HEp-2 and WiDr cells) which is the 8-peroxidized form of 6, are less cytotoxic than the Mar. Drugs 2011, 9  
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corresponding 8-hydroxy derivatives 3, 4 and 6, respectively; therefore, it was found that the hydroxy 
group  at  C-8  could  enhance  the  cytotoxicity  of  cembranoids  1–7,  in  comparison  with  the  C-8 
hydroperoxy-bearing  analogues.  In  the  present  study,  the  in  vitro  anti-inflammatory  effects  of 
compounds 1–7 were also tested by examining the inhibitory activity of these compounds toward the 
LPS-induced  up-regulation  of  pro-inflammatory  proteins,  iNOS  and  COX-2  in  RAW264.7 
macrophage cells (Figure 4). At a concentration of 10 μM, compounds 1–7 were found to significantly 
reduce the levels of iNOS protein, relative to the control cells stimulated with LPS only. Furthermore, 
at the same concentration, metabolite 4 also could effectively reduce COX-2 expression with LPS 
treatment. Thus, compounds 1–7 might be useful anti-inflammatory agents, while 4 is a promising 
anti-inflammatory lead compound as 4 significantly inhibited the expression of both iNOS and COX-2 
proteins.  Compared  to  the  biological  activities  of  known  cembranoids  [9–24],  1–7  have  shown 
satisfactory bioactivities and may warrant further study. 
Table 4. Cytotoxicity of compounds 1–7 (ED50 μM). 
Compound  Daoy  HEp-2  MCF-7  WiDr 
1  7.3 ±  1.7  15.0 ±  1.9  19.4 ±  2.4  18.4 ±  0.9 
2  8.3 ±  1.4  16.5 ±  1.7  9.6 ±  2.7  18.9 ±  1.9 
3  6.4 ±  2.0  13.5 ±  2.5  9.4 ±  2.5  18.7 ±  1.0 
4  5.1 ±  1.2  5.8 ±  0.5  8.4 ±  1.5  6.4 ±  2.0 
5  >20  >20  >20  >20 
6  9.9 ±  4.0  >20  10.2 ±  1.0  >20 
7  >20  >20  >20  >20 
Mitomycin-C  0.44 ±  0.06  0.30 ±  0.06  0.30 ±  0.12  0.47 ±  0.12 
Figure  4.  Effect  of  compounds  1–7  on  iNOS  and  COX-2  proteins  expression  of 
RAW264.7  macrophage  cells  by  immunoblot  analysis:  (A)  Immunoblots  of  iNOS  and  
β-actin; (B) Immunoblots of COX-2 and β-actin. The values are mean ±  SEM (n = 6). 
Relative intensity of the LPS alone stimulated group was taken as 100 %.* Significantly 
different from LPS alone stimulated group (* P < 0.05). 
a stimulated with LPS, 
b stimulated 
with LPS in the presence of 1–7 (10 μM).  
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3. Experimental Section 
3.1. General Experimental Procedures 
Melting points were determined using a Fisher-Johns melting point apparatus. Optical rotations 
were measured on a JASCO P-1020 polarimeter. Ultraviolet spectra were recorded on a JASCO V-650 
spectrophotometer. IR spectra were recorded on a JASCO FT/IR-4100 infrared spectrophotometer. 
The  NMR  spectra  were  recorded  on  a  Varian  400MR  FT-NMR  (or  Varian  Unity  INOVA500  
FT-NMR) instrument at 400 MHz (or 500 MHz) for 
1H and 100 MHz (or 125 MHz) for 
13C in CDCl3. 
LRMS and HRMS were obtained by ESI on a Bruker APEX II mass spectrometer. Silica gel (Merck, 
230–400 mesh) was used for column chromatography. Precoated silica gel plates (Merck, Kieselgel 60 
F-254,  0.2  mm)  were  used  for  analytical  TLC.  High-performance  liquid  chromatography  was 
performed on a Hitachi L-7100 HPLC apparatus with a Merck Hibar Si-60 column (250 ×  21 mm, 
7 μm) and on a Hitachi L-2455 HPLC apparatus with a Supelco C18 column (250 ×  21.2 mm, 5 μm). 
3.2. Animal Material 
S.  crassocaule (specimen no. 20070402), taxonomically identified by Prof. Chang-Feng Dai of 
National Taiwan University, was collected by hand using scuba off the coast of Dongsha, Taiwan, in 
April 2007, at a depth of 5–10 m, and stored in a freezer until extraction. A voucher sample was 
deposited at the Department of Marine Biotechnology and Resources, National Sun Yat-sen University. 
3.3. Extraction and Separation 
The frozen bodies of S. crassocaule (0.5 kg, wet wt) were minced and exhaustively extracted with 
EtOAc  (1  L  ×   5).  The  EtOAc  extract  (7.3  g)  was  chromatographed  over  silica  gel  by  column 
chromatography and eluted with EtOAc in n-hexane (0–100%, stepwise), then with acetone in EtOAc 
(50–100%,  stepwise)  to  yield  28  fractions.  Fraction  17,  eluting  with  n-hexane–EtOAc  (1:1),  was 
further purified over silica gel using n-hexane–acetone (3:1) to afford seven subfractions (C1–C7). 
Subfraction C5 was purified by reverse-phase HPLC using MeOH–H2O (3:2) to afford 5 (2.2 mg). 
Subfraction C7 was separated by reverse-phase HPLC using MeOH–H2O (7:5) to afford 1 (6.3 mg) 
and 2 (9.3 mg). Fraction 18, eluting with n-hexane–EtOAc (1:1), and was further purified over silica 
gel using n-hexane–Acetone (3:1) to afford seven subfractions (D1–D7). Subfraction D3 was separated 
by reverse-phase HPLC using MeOH–H2O (3:2) to afford 6 (3.7 mg) and 7 (2.6 mg). Fraction 19, eluting 
with  n-hexane–EtOAc  (1:2),  and  was  further  purified  over  silica  gel  using  n-hexane–Acetone  (2:1)  
to afford seven subfractions (E1–E7). Subfraction E5 was separated by reverse-phase HPLC using 
MeOH–H2O (3:2) to afford 3 (5.2 mg) and 4 (4.3 mg). 
Sarcocrassocolide F (1): white solid; mp 92.0–95.0 ° C; [ʱ]
25
D −42 (c 0.6, CHCl3); IR (neat) νmax 3403, 
3014, 2974, 2933, 1757, 1659, 1430, 1371, 1273 and 1228 cm
−1; UV (MeOH) λmax 213   ε = 3.8); 
13C and 
1H NMR data, see Tables 1 and 2; ESIMS m/z 429 [M + Na]
+; HRESIMS m/z 429.1887  
[M + Na]
+ (calcd for C22H30O7Na, 429.1889). 
Sarcocrassocolide G (2): colorless oil; [ʱ]
25
D −56 (c 0.6, CHCl3); IR (neat) νmax 3420, 2969, 2931, 
2859, 1758, 1714, 1659, 1431, 1372, 1273 and 1229 cm
−1; UV (MeOH) λmax 209   ε = 3.7); 
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1H NMR data, see Tables 1 and 2; 
1H NMR (Pyridine-d5, 500 MHz) δ 3.38 (1H, dt, J = 11.5, 3.0 Hz, 
H-1), 1.94 (1H, m, H-2a), 1.82 (1H, m, H-2b), 2.81 (1H, t, J = 6.0 Hz, H-3), 2.51 (1H, dd, J = 14.5,  
7.0 Hz, 5a), 2.33 (1H, dd, J = 14.5, 7.0 Hz, 5b), 5.63 (1H, dt, J = 16.0, 7.0 Hz, H-6), 5.89 (1H, d,  
J = 16.0 Hz, H-7), 2.06 (1H, ddd, J = 10.0, 5.0, 3.5 Hz, H-9a), 1.97 (1H, dt, J = 13.5, 5.0 Hz, H-9b), 
2.22 (2H, m, H2-10), 5.66 (1H, brs), 5.81 (1H, s), 4.91 (1H, t, J = 3.0 Hz, H-14), 6.45 (1H, d, J = 2.5 Hz, 
H-17a), 5.76 (1H, d, J = 2.5 Hz, H-17b), 1.30 (3H, s, H3-18), 1.55 (1H, s, H3-19), 1.80 (1H, s, H3-20), 
2.03 (3H, s, 13-OAc), 13.04 (1H, s, 8-OOH); 
13C NMR (Pyridine-d5, 125 MHz) δ 38.7 (CH, C-1),  
35.7 (CH2, C-2), 59.3 (CH, C-3), 59.8 (qC, C-4), 39.6 (CH2, C-5), 124.6 (CH, C-6), 139.2 (CH, C-7), 
84.7 (qC, C-8), 37.9 (CH2, C-9), 22.4 (CH2, C-10), 130.0 (CH, C-11), 130.2 (qC, C-12), 78.1 (CH, C-13), 
82.6 (CH, C-14), 140.7 (qC, C-15), 169.9 (qC, C-16), 122.4 (CH2, C-17), 18.7 (CH3, C-18), 22.4 (CH3, 
C-19),  15.5  (CH3,  C-20),  21.0  (CH3,  C-OAc),  170.2  (qC,  C-OAc);  ESIMS  m/z  429  [M  +  Na]
+; 
HRESIMS m/z 429.1886 [M + Na]
+ (calcd for C22H30O7Na, 429.1889). 
Sarcocrassocolide H (3): colorless oil; [ʱ]
25
D −17 (c 0.5, CHCl3); IR (neat) νmax 3479, 2966, 2927, 
2856, 1758, 1659, 1432, 1370, 1273 and 1228 cm
−1; UV (MeOH) λmax 214   ε = 3.8); 
13C and 
1H NMR data, see Tables 1 and 2; ESIMS m/z 413 [M + Na]
+; HRESIMS m/z 413.1937 [M + Na]
+  
(calcd for C22H30O6Na, 413.1940). 
Sarcocrassocolide I (4): colorless oil; [ʱ]
25
D −29 (c 0.4, CHCl3); IR (neat) νmax 3479, 2964, 2926, 
2855, 1758, 1658, 1433, 1371, 1273 and 1230 cm
−1; UV (MeOH) λmax 212   ε = 3.7); 
13C and 
1H NMR data, see Tables 1 and 2; ESIMS m/z 413 [M + Na]
+; HRESIMS m/z 413.1938 [M + Na]
+ 
(calcd for C22H30O6Na, 413.1940).  
Sarcocrassocolide J (5): colorless oil; [ʱ]
25
D −142 (c 0.1, CHCl3); IR (neat) νmax 3382, 2961, 2928, 
2857, 1760, 1659, 1431, 1384, 1268 and 1231 cm
−1; UV (MeOH) λmax 213   ε = 3.8); 
13C and 
1H NMR data, see Tables 1 and 3; ESIMS m/z 371 [M + Na]
+; HRESIMS m/z 371.1837 [M + Na]
+ 
(calcd for C20H28O5Na, 371.1834). 
Sarcocrassocolide K (6): colorless oil; [ʱ]
25
D −51 (c 0.3, CHCl3); IR (neat) νmax 3471, 2965, 2925, 
2856, 1759, 1659, 1384 and 1266 cm
−1; UV (MeOH) λmax 208   ε = 3.7); 
13C and 
1H NMR data, see 
Tables  1  and  3;  ESIMS  m/z  355  [M  +  Na]
+;  HRESIMS  m/z  355.1888  [M  +  Na]
+  (calcd  for 
C20H28O4Na, 355.1885). 
Sarcocrassocolide L (7): white solid; mp 85–87 ° C; [ʱ]
25
D −140 (c 0.2, CHCl3); IR (neat) νmax 3445, 
2965, 2925, 2854, 1759, 1654, 1455, 1374 and 1267 cm
−1; UV (MeOH) λmax 208   ε = 3.6); 
13C and 
1H NMR data, see Tables 1 and 3; ESIMS m/z 355 [M + Na]
+ ;HRESIMS m/z 355.1883 [M + Na]
+ 
(calcd for C20H28O4Na, 355.1885).  
Reduction of sarcocrassocolide F (1). A solution of 1 (1.0 mg) in diethyl ether (3 mL) was added 
excess amount triphenylphosphine and the mixture was stirred at room temperature for 4 h. The solution 
was concentrated under reduced pressure to afford a residue which was subjected to reversed-phase 
HPLC with MeOH–H2O (3:2) to yield 3 (0.8 mg, 83%). 
Reduction of sarcocrassocolide G (2). By using the same reaction and purification procedures as the 
reduction of 1, the solution of 2 (1.0 mg) was converted to 4 (0.7 mg) in 73% yield. Mar. Drugs 2011, 9  
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Reduction of sarcocrassocolide J (5). By using the same reaction and purification procedures as the 
reduction of 1, the solution of 5 (0.5 mg) was converted to 6 (0.4 mg) in 84% yield. 
3.4. Cytotoxicity Testing  
Cell lines were purchased from the American Type Culture Collection (ATCC). Cytotoxicity assays 
of compounds 1–7 were performed using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] colorimetric method [25,26]. 
3.5. In Vitro Anti-Inflammatory Assay 
Macrophage (RAW264.7) cell line was purchased from ATCC. In vitro anti-inflammatory activities 
of compounds 1–7 were measured by examining the inhibition of lipopolysaccharide (LPS) induced 
upregulation of iNOS (inducible nitric oxide synthetase) and COX-2 (cyclooxygenase-2) proteins in 
macrophages cells using western blotting analysis [27,28]. 
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